| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks
1 company
Flemming Steen Jensen is See Remarks at ASND. Flemming Steen Jensen's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider.
Flemming Steen Jensen has 1 Form 4 filing on record in May 2026, as Ascendis Pharma A/S (ASND), 2026.
The 1 reported transaction was 1 open-market sale.
Counted by filing, the open-market trades come to no purchases and 1 sale worth about $4.6M.
The only open-market sale was 19,460 shares of ASND at an average $238.49 on May 11, 2026, about $4.6M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | ASND Ascendis Pharma A/s | See Remarks | Sell | 19,460 | $238.49 | $4,641,021.24 | -100% | +7.1% | - |